Complete Catalog β 92 Compounds
AllPeptides
92 compounds across every goal β CoA-verified on every batch, from skin collagen to telomere extension to GLP-1 fat-loss protocols.
Staff Picks
Semaglutide
Long-half-life GLP-1 receptor agonist studied in the STEP weight-management trials. Available in five vial sizes from 3 mg through 30 mg to match research-protocol duration; all sizes draw from the same batch and CoA.
Browse by Goal
Showing 92 peptides
Semaglutide
Long-half-life GLP-1 receptor agonist studied in the STEP weight-management trials. Available in five vial sizes from 3 mg through 30 mg to match research-protocol duration; all sizes draw from the same batch and CoA.
Tirzepatide
Dual incretin agonist engaging both GLP-1 and GIP receptors. Studied in SURMOUNT-1 (22.5% weight reduction at 72 weeks). Available in 15 mg, 30 mg, and 60 mg vials.
Retatrutide
Triple incretin agonist reported to produce 24.2% body-weight reduction at 48 weeks in NEJM Phase 2 data (2023). Available across four vial sizes from 10 mg through 30 mg.
CagriReta
Amylin-analogue cagrilintide combined with triple-agonist retatrutide for researchers exploring additive satiety and energy-balance pathways. Available in 5 mg and 10 mg sizes.
Cagrilintide
Acylated amylin analogue designed for once-weekly subcutaneous dosing. Studied alongside semaglutide and retatrutide for combined incretin/amylin research. Available in 5 mg and 10 mg.
Sermorelin
Truncated GHRH analogue covering the first 29 residues β the portion sufficient for pituitary GH-release activity. Available as 2 mg, 5 mg, or 10 mg vials.
Tesamorelin
N-terminally trans-3-hexenoyl-modified GHRH(1-44) with enhanced plasma stability. Research focus on visceral-adipose reduction. Available in 10 mg and 20 mg sizes.
Thymosin Alpha-1
Acetylated N-terminal fragment of prothymosin-Ξ±, studied for T-cell maturation and innate-immune modulation. Available in 5 mg and 10 mg research vials.
CJC-1295 (No DAC)
CJC-1295 without the Drug Affinity Complex β ~30 minute half-life, preserves pulsatile GH release. Research vials in 5 mg and 10 mg.
AOD-9604
Modified 16-residue C-terminal fragment of human growth hormone (177-191), engineered to retain lipolytic activity without the metabolic effects of full-length hGH. Available in 2 mg, 5 mg, and 10 mg.
Adipotide (FTTP)
Fat-targeting proapoptotic peptide studied in primate adiposity models by Arap & Pasqualini. Available in 5 mg and 10 mg research vials.
BAM15
Small-molecule mitochondrial protonophore studied as a tissue-safe alternative to DNP for thermogenesis research. Available as 30 mg/mL or 50 mg/mL in 30 mL.
L-Carnitine
Quaternary ammonium compound required for long-chain fatty-acid transport into mitochondria. Available in two concentrations and a 5-pack.
SLU-PP-332 (Liquid)
Estrogen-related-receptor agonist studied for endurance and mitochondrial biogenesis. Liquid formulation in two concentrations.
SLU-PP-332 (Capsules)
Estrogen-related-receptor agonist studied for endurance and mitochondrial biogenesis. Capsule format across three strength/count combinations.
RU-58841
Non-steroidal anti-androgen researched for scalp-localized androgen-receptor blockade in hair-follicle models. Available in 30 mL and 60 mL bottles.
Epitalon
Four-residue synthetic peptide derived from Epithalamin, the pineal extract characterized by Khavinson. Available in 10 mg and 50 mg vials.
GHK-Cu
Glycyl-L-histidyl-L-lysine coordinated with Cu(II) β the Pickart copper-tripeptide metallopeptide studied for collagen remodelling and matrix signalling. 50 mg and 100 mg vials.
NAD+
Cofactor for sirtuin and PARP enzymes implicated in DNA-repair and metabolic longevity programs. Available in 500 mg and 1000 mg sizes.
Glutathione
Gamma-glutamyl-cysteinyl-glycine β the primary intracellular antioxidant. Research vials in 200 mg, 600 mg, and 1500 mg.
MOTS-c
16-residue peptide encoded by the 12S rRNA region of mitochondrial DNA. Studied for metabolic homeostasis and exercise-response modulation. Available in 10, 20, and 40 mg sizes.
SS-31 (Elamipretide)
D-Arg-dimethyl-Tyr-Lys-Phe-NHβ β a cationic peptide that concentrates in the inner mitochondrial membrane and binds cardiolipin. Available in 10, 25, and 50 mg.
Pinealon
Short synthetic tripeptide studied by the Khavinson group for neuroprotection and cognitive-aging endpoints. Available in 10 mg and 20 mg.
DSIP (Delta Sleep-Inducing Peptide)
Nonapeptide characterized by Monnier in the 1970s for its effects on delta-wave EEG activity. Available as 5, 10, and 15 mg research vials.
N-Acetyl Selank Amidate
N-acetylated, C-amidated variant of the Semax-family nootropic Selank, designed for intranasal stability. Available in 10 mg and 30 mg.
Kisspeptin-10
C-terminal decapeptide of kisspeptin β the primary endogenous driver of GnRH release. Available in 5 mg and 10 mg.
Oxytocin
Endogenous nonapeptide hormone studied for social-bonding, pair-bonding, and stress-response research. Available in 8 mg and 10 mg.
VIP (Vasoactive Intestinal Peptide)
Vasoactive intestinal peptide β 28-residue neuropeptide studied for smooth-muscle relaxation and mast-cell stabilization research. Available in 5 mg and 10 mg.
KPV
Lysine-proline-valine β the C-terminal tripeptide of Ξ±-MSH studied for anti-inflammatory and gut-barrier endpoints. Available in 5 mg and 10 mg.
5-Amino-1MQ
Nicotinamide N-methyltransferase inhibitor studied for white-adipose NAD+ preservation and metabolic endpoints. Lyophilized research vials; 5 mg and 50 mg.
BPC-157 + TB-500 Blend
Co-lyophilized blend of BPC-157 (angiogenic signalling) and TB-500 (actin-motility). Available in matched 5+5 mg and 10+10 mg ratios.
Ipamorelin + Tesamorelin Blend
Co-formulated ipamorelin (GHRP, ghrelin-receptor agonist) with tesamorelin (stabilized GHRH). Two ipamorelin-dose variants over constant 10 mg tesamorelin.
Ipamorelin + CJC-1295 Blend
Co-formulated ipamorelin with CJC-1295 (no-DAC). Dual ghrelin/GHRH stimulation studied for pulsatile GH release. Available as matched 5+5 mg.
BPC-157 10mg
A 15-amino-acid sequence isolated from body protection compound found in gastric juice. Investigated extensively for tendon, ligament, and intestinal lining repair β this 10mg vial is the common research protocol size.
IGF-1 LR3 1mg
IGF-1 LR3 is a long-R3 analogue of native IGF-1 β an 83-residue recombinant protein with Arg3 substitution and a 13-residue N-terminal extension that extends plasma half-life from minutes to roughly twelve hours and dramatically weakens IGFBP binding.
Ipamorelin 10mg
Pentapeptide selective agonist at the ghrelin receptor (GHSR-1a). Triggers pulsatile growth hormone release without the cortisol, prolactin, or aldosterone elevations seen with earlier GHRPs.
TB-500 10mg
Synthetic fragment of Thymosin Beta-4 β a 43-amino-acid protein that sequesters G-actin and drives cell migration to sites of injury. Long half-life permits a twice-weekly loading cadence, very different from daily BPC-157.
5-Amino-1MQ 50mg x60 Capsules
5-Amino-1MQ in a 60-capsule bottle at 50mg per capsule β the oral-delivery format of the NNMT inhibitor, supplying roughly two months of daily research dosing in a single bottle.
ACE-031 1mg
ACE-031 1mg β a soluble ActRIIB-Fc fusion trap developed by Acceleron Pharma that sequesters myostatin and other TGF-Ξ² superfamily ligands to block negative regulation of muscle growth.
AICAR 50mg
AICAR 50mg β 5-Aminoimidazole-4-carboxamide ribonucleoside, a small-molecule AMPK activator famously described as "exercise in a pill" after the 2008 Narkar Salk Institute endurance study.
ARA-290 10mg
Eleven-amino-acid fragment of erythropoietin (sequence QEQLERALNSS) that activates the innate repair receptor without raising hematocrit. Originally developed by Araim Pharmaceuticals for sarcoidosis neuropathy.
Abaloparatide 3mg
Abaloparatide 3mg β the FDA-approved PTHrP-based osteoanabolic analog (Tymlos, 2017), structurally engineered from parathyroid-hormone-related protein rather than PTH itself to bias the receptor-binding conformation and improve the anabolic-to-catabolic ratio in bone.
Adamax 10mg
Adamax 10mg β an unusual hybrid within the Khavinson catalogue, combining thymus-positioned and pineal-positioned short-peptide fragments in one preparation to target neuroimmune axis research.
BPC-157 Capsules 500mcg x60
Sixty oral capsules at 500mcg each β 30mg total. Uses BPC-157's unusual oral stability (most peptides are destroyed in the stomach; this pentadecapeptide survives) to deliver gut-focused research without an injection.
Bacteriostatic Water 30mL
Sterile water with 0.9% benzyl alcohol as a bacteriostatic preservative β the solvent used to reconstitute every lyophilized peptide in your protocol. One 30mL vial handles roughly 15β30 reconstitutions, depending on peptide volume.
Bacteriostatic Water USP 30mL
USP-grade sterile water with 0.9% benzyl alcohol β the pharmacopeia-verified reconstitution solvent. Identical function to standard bacteriostatic water but manufactured and tested against United States Pharmacopeia monograph standards.
Bronchogen 20mg
Bronchogen is a Khavinson-class short peptide bioregulator positioned for bronchial epithelium research β one of the sixteen tissue-targeted oligopeptides developed at the St. Petersburg Institute of Bioregulation and Gerontology from the original lung-extract drug Bronchalamin.
CJC-1295 with DAC 10mg
CJC-1295 with DAC 10mg β the albumin-tethered GHRH analog that holds a steady-state GH elevation across roughly eight days from a single subcutaneous dose.
Cagri-Sema Blend 10mg
The 5mg Cagrilintide + 10mg Semaglutide co-formulated blend β a fixed-ratio research-format version of Novo Nordisk's CagriSema development program (REDEFINE-1 and REDEFINE-2 phase 3 trials), pairing long-acting amylin analog with GLP-1 agonism.
Cardiogen 20mg
Cardiogen β the myocardial entry in Khavinson's bioregulator series β is a short peptide (commonly written as Ala-Glu-Asp-Arg) extracted from work on calf cardiac tissue and taken as a synthetic successor to the heart-derived drug Kardiolin.
Cartalax 20mg
Cartalax is the cartilage-positioned Khavinson tetrapeptide (Ala-Glu-Asp-Leu, AEDL), researched as a chondrocyte-selective successor to the joint-tissue extract Cartalin and typically paired with Pinealon in age-related musculoskeletal work.
Chonluten 20mg
Chonluten is a Glu-Asp-Gly (EDG) tripeptide in the Khavinson series positioned for bronchial and gastric mucosal research β and one of the few in the series where some Western investigators have replicated mucin- and proliferation-marker endpoints.
Cortagen 20mg
Cortagen is a Khavinson tetrapeptide positioned for cerebral-cortex research β the neurological companion to Epitalon, derived from work on calf cortical tissue extract (Cortexin) and intended as its synthetic successor.
Crystagen 20mg
Crystagen is the second thymic peptide in the Khavinson series β a Glu-Asp-Pro (EDP) tripeptide positioned alongside Thymogen and Vilon as one of three immune-system bioregulators the framework assigns to thymic function in ageing.
FOXO4-DRI 10mg
FOXO4-DRI 10mg β the D-retro-inverso proteolysis-resistant peptide from Peter de Keizer's Erasmus MC senolytic work, engineered to disrupt the FOXO4βp53 interaction that protects senescent cells from apoptosis.
GHRP-2 10mg
GHRP-2 10mg β a hexapeptide ghrelin-receptor agonist (D-Ala-D-Ξ²-Nal-Ala-Trp-D-Phe-Lys-NH2) developed at Tulane, favored for clean GH elevation with minimal cortisol or prolactin lift.
GHRP-6 10mg
GHRP-6 10mg β the original His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 hexapeptide from the Bowers lab, distinguished by its strong orexigenic signal alongside GHS-R1a activation.
GLOW Blend 50mg
GLOW is a community-origin triple blend β GHK-Cu (copper tripeptide) + BPC-157 + TB-500 β assembled to combine Pickart's dermal collagen pharmacology with the orthogonal BPC/TB repair duo for aesthetic/skin research in one vial.
GLOW Blend 70mg
The extended 70mg format of the GHK-Cu + BPC-157 + TB-500 triple stack β sized for multi-month aesthetic research arcs where the 50mg format would force a reconstitution mid-study.
Gonadorelin Acetate
Gonadorelin Acetate β the native decapeptide sequence of GnRH (pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2), used to probe pituitary gonadotrope response and upstream HPG-axis integrity.
Hexarelin 5mg
Hexarelin 5mg β the methylated-His GHRP variant (His-D-MeTrp-Ala-Trp-D-Phe-Lys-NH2) with highest peak GH potency in the hexapeptide class, paired with faster receptor desensitization.
IPA/TESA Blend 15mg
The 5mg Ipamorelin + 10mg Tesamorelin co-formulated blend β pairs the selective GHSR-1a pentapeptide with the FDA-approved (Egrifta) stabilised GHRH(1-44) analog for a dual-agonist secretagogue stack with a clinically-validated GHRH component.
KLOW Blend 80mg
KLOW adds KPV (the Ξ±-MSH fragment tripeptide lysine-proline-valine) to the GLOW triple stack, giving a four-compound gut/skin research blend that combines anti-inflammatory melanocortin signalling with the three-axis repair logic of GHK-Cu/BPC/TB.
LL-37 10mg
The body's only human cathelicidin-derived antimicrobial peptide β 37 residues of broad-spectrum innate immunity. Disrupts bacterial membranes directly while also signalling to human immune cells as a cytokine-like alarm molecule.
Livagen 20mg
Livagen is a Lys-Glu-Asp-Ala (KEDA) tetrapeptide in the Khavinson series targeted to hepatic tissue β a synthetic successor to the calf-liver peptide extract Epithalon, positioned for research on hepatocyte function in ageing.
Mazdutide 6mg
Mazdutide (IBI362) β Innovent Biologics' long-acting GLP-1/glucagon dual agonist, the oxyntomodulin analog licensed from Eli Lilly that received Chinese NMPA approval in 2025 for obesity and T2D.
Melanotan I 10mg
Melanotan I 10mg β afamelanotide, the more MC1R-selective Ξ±-MSH analog developed at the University of Arizona, pharmacologically distinct from Melanotan II and clinically approved (Scenesse, 2019) for erythropoietic protoporphyria.
Melanotan II 10mg
Melanotan II 10mg β the shorter, nonselective Ξ±-MSH analog from the same University of Arizona program that produced afamelanotide, the precursor molecule that PT-141 was deliberately engineered to improve upon.
Methylene Blue 10mg/mL 50mL
Methylene Blue 10mg/mL 50mL β the oldest synthetic pharmaceutical still in clinical use (Ehrlich, 1880s), a phenothiazine redox dye explicitly not a peptide, studied for mitochondrial electron-transport bypass and cognitive-bioenergetics research.
N-Acetyl Semax Amidate 30mg
N-Acetyl Semax Amidate 30mg β the N-acetylated, C-amidated stability-extended variant of Semax, originally derived from ACTH(4-10) at the Institute of Molecular Genetics in Moscow.
NA-Epitalon 10mg
NA-Epitalon 10mg β the N-acetyl, C-amidated stability-enhanced variant of the Khavinson Ala-Glu-Asp-Gly tetrapeptide, engineered to survive longer in circulation than the unmodified parent sequence.
O-304 (ATX-304) 100mg x60 Capsules
O-304 / ATX-304 β a direct pan-AMPK activator developed by Betagenon and licensed to Atrogi, positioned as an exercise-mimetic small molecule that activates the Ξ±1Ξ²1Ξ³1, Ξ±1Ξ²2Ξ³1, and Ξ±2Ξ²1Ξ³1 AMPK isoforms at low micromolar potency.
Ovagen 20mg
Ovagen is one of the more confusingly named entries in the Khavinson series: despite its name it is positioned for hepatic and gastrointestinal research rather than ovarian tissue, with the tripeptide sequence Glu-Asp-Leu (EDL) assigned to upper-GI mucosal cells.
P21 10mg
P21 10mg β a short peptide derived from ciliary neurotrophic factor (CNTF), investigated in adult-hippocampal-neurogenesis research as a non-mitogenic fragment that triggers CNTF-receptor signaling for memory-formation endpoints.
PE-22-28 10mg
PE-22-28 10mg β a spadin-derived seven-residue peptide investigated as a selective TREK-1 channel inhibitor, the first mechanistically distinct rapid-onset antidepressant target class since ketamine.
PEG-MGF 2mg
PEG-MGF 2mg β the pegylated, stability-extended form of Mechano Growth Factor (the IGF-1Ec splice variant), engineered to survive plasma circulation long enough to reach target tissue.
PNC-27 30mg
PNC-27 is a 32-residue fusion peptide β p53 residues 12-26 tethered to a leucine-zipper membrane-residency domain β developed at Weill Cornell/Albert Einstein as a cancer-cell-selective membrane-disrupting research tool, not an anti-aging compound.
PT-141 10mg
PT-141 10mg β bremelanotide, the FDA-approved (Vyleesi) melanocortin-receptor agonist derived from Melanotan II, clinically validated for hypoactive sexual desire disorder and mechanistically unrelated to the longevity peptides it is shelved with.
Pancragen 20mg
Pancragen is the Khavinson series' pancreatic bioregulator β a Lys-Glu-Asp-Trp (KEDW) tetrapeptide positioned for research on islet and exocrine pancreatic cells in ageing, paired canonically with Livagen for the hepatic/pancreatic metabolic axis.
Prostamax 20mg
Prostamax is the prostate-positioned synthetic tetrapeptide in the Khavinson series, successor to the earlier bovine-prostate extract Prostatilen β a drug with a substantial Soviet-era urology track record that informs how the synthetic representative is studied today.
Reta-Cagri 5mg/5mg
The 5mg Retatrutide + 5mg Cagrilintide co-formulated blend β a speculative four-receptor research stack pairing Lilly's GLP-1/GIP/glucagon triple agonist with Novo's long-acting amylin analog, covering amylin + GLP-1 + GIP + glucagon in a single injection.
SNAP-8 10mg
SNAP-8 is acetyl octapeptide-3 β an elongated Argireline analog extending the SNAP-25 N-terminal mimetic sequence by one residue for stronger competitive binding at the SNARE complex, used in topical cosmetic research on expression-line attenuation.
Selank 10mg
Selank 10mg β the unmodified Thr-Lys-Pro-Arg-Pro-Gly-Pro heptapeptide from the original Moscow Institute publications, supplied without the N-acetyl or C-amide stability modifications of the amidate variant.
Survodutide 10mg
Survodutide (BI 456906) β the Boehringer Ingelheim/Zealand Pharma GLP-1/glucagon dual agonist that cleared Phase 2 MASH in 2024 with a 83% fibrosis-improvement response rate at the top dose.
Tesofensine 500mcg x30 Capsules
Tesofensine β a small-molecule triple monoamine reuptake inhibitor (dopamine, norepinephrine, serotonin) originally developed by NeuroSearch as an Alzheimer's candidate, reclassified into obesity research after Phase 2 showed 12.5kg mean weight loss at 1mg over 24 weeks.
Tesofensine 500mcg x30 Tablets
The pressed-tablet format β identical 500mcg tesofensine dose as the capsule variant, differentiated by faster GI disintegration kinetics and the practical option to split the tablet for lower-dose titration research.
Testagen 20mg
Testagen is the Khavinson testicular-tissue bioregulator β a short peptide (Lys-Glu-Asp-Gly, KEDG, in most Khavinson references) positioned for Leydig and seminiferous tubule research rather than as a testosterone-elevating peptide.
Thymogen 20mg
Thymogen is the founder peptide of the Khavinson synthetic bioregulator series β a Glu-Trp (EW) dipeptide, the shortest in the catalogue, derived from the Soviet-era thymic tissue drug Thymalin and with a longer Russian clinical track record than any other entry in this class.
Thymulin 10mg
Thymulin is a different kind of thymic peptide from the Khavinson series β a nine-residue zinc-binding nonapeptide (Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) isolated by Bach's group in Paris in the 1970s, historically known as βserum thymic factorβ or Facteur Thymique SΓ©rique (FTS).
Vesilute 20mg
Vesilute is the urinary-tract bioregulator in the Khavinson series β positioned for bladder detrusor and urothelial research, a narrower and less-studied tissue slot than most of the catalogue occupies.
Vesugen 20mg
Vesugen is the vascular-endothelium bioregulator in the Khavinson series β a Lys-Glu-Asp (KED) tripeptide positioned for research on endothelial ageing and vessel-wall cell turnover, paired canonically with Cardiogen in cardiovascular research protocols.
Vilon 20mg
Vilon is a Lys-Glu (KE) dipeptide β the second minimal peptide to emerge from the Khavinson program β specifically studied across a cluster of aged-rodent lifespan-extension experiments that remain some of the most-cited data in the series.
Premium Peptide Catalog
Shop the Complete Catalog
92 premium compounds for looks maxing, body composition, longevity, and peak performance β pharmaceutical-grade, certificate of analysis verified on every batch.
Shop Now
